News
Acies Bio and EWN JV development
11.07.2018 Acies Bio has established Whey2Value, a new, German-based joint venture [...]
EWRS Sponsorship
26.06.2018 Acies Bio is glad to have supported the organization of the 18th European [...]
Process improvements grant received
03.05.2018 Acies
Bio received a grant within public call for “Process improvements [...]
METABOLIC ENGINEERING 12
16.04.2018 ACIES BIO is proud to support the upcoming scientific conference Metabolic [...]
ACIES BIO AWARDED GOLD AAA Creditworthiness certificate
05.02.2018 The most prominent partner of Dun & Bradstreet,
analytical company [...]
ACIES BIO CHAIRMAN AWARDED YOUNG MANAGER OF THE YEAR
26.01.2018 The year 2017 was a breakthrough year for Acies Bio. Three internal [...]
ACIES BIO RECEIVES A H2020 – SME INST GRANT FROM THE EUROPEAN UNION
26.10.2017 Whey2Value technology has been awarded a substantial grant from EU Horizon [...]
TM3 THERAPEUTICS PUBLISHED IN VIVO PROOF OF CONCEPT DATA FOR TREATMENT OF PKAN
13.09.2017 TM3 Therapeutics, a spin-off of ACIES BIO, is a biopharmaceutical company [...]
Innovation potential and competences grant received
06.07.2017 Within the public call
»Enhancing innovation potential and competences in [...]